Published in J Clin Invest on January 01, 1995
Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin. J Exp Med (1996) 1.36
Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets. Front Immunol (2014) 1.04
Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy. Oncoimmunology (2015) 0.86
The surface epithelium of recurrent infected palatine tonsils is rich in gammadelta T cells. Clin Exp Immunol (1998) 0.82
Afferent lymph veiled cells stimulate proliferative responses in allogeneic CD4+ and CD8+ T cells but not gamma delta TCR+ T cells. Immunology (1996) 0.80
Dendritic cells: potential role in cancer therapy. Cytotechnology (1997) 0.78
Co-stimulatory signals increase the reactivity of gammadelta T cells towards mycobacterial antigens. Clin Exp Immunol (2000) 0.76
The expansion of human gammadelta T cells in response to Daudi cells requires the participation of CD4+ T cells. Immunology (1999) 0.75
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med (1991) 8.78
Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science (1989) 7.78
The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol (1993) 5.65
Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck. Nature (1989) 5.20
Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science (1991) 5.12
Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature (1989) 4.61
B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol (1989) 4.61
Gamma/delta cells. Annu Rev Immunol (1993) 4.35
Isolation of CD4- CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature (1989) 3.79
The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci U S A (1990) 3.71
Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med (1989) 3.70
Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens. J Immunol (1981) 3.69
B70 antigen is a second ligand for CTLA-4 and CD28. Nature (1993) 3.57
Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature (1989) 3.49
Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Nature (1993) 3.47
Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol (1991) 3.12
Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells. Cell Immunol (1988) 3.05
The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature (1991) 2.76
The nature of major histocompatibility complex recognition by gamma delta T cells. Cell (1994) 2.64
The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. J Clin Invest (1992) 2.51
Molecular biology and function of CD4 and CD8. Adv Immunol (1989) 2.01
Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med (1993) 1.98
Biology of the human gamma delta T-cell receptor. Immunol Rev (1991) 1.97
Tissue localization and CD8 accessory molecule expression of T gamma delta cells in humans. J Immunol (1989) 1.96
T cell receptor gamma/delta+ lymphocyte subsets during HIV infection. Clin Exp Immunol (1989) 1.72
Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J Clin Invest (1990) 1.72
Gamma delta T cell receptor-bearing lymphocytes during Epstein-Barr virus infection. J Infect Dis (1990) 1.71
Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3. J Immunol (1986) 1.52
Structure and specificity of a class II MHC alloreactive gamma delta T cell receptor heterodimer. Science (1989) 1.50
Crosstalk between alpha/beta T cells and gamma/delta T cells in vivo: activation of alpha/beta T-cell responses after gamma/delta T-cell modulation with the monoclonal antibody GL3. Proc Natl Acad Sci U S A (1993) 1.50
A subset of gamma delta lymphocytes is increased during HIV-1 infection. Clin Exp Immunol (1991) 1.49
Specific recognition of staphylococcal enterotoxin A by human T cells bearing receptors with the V gamma 9 region. Nature (1990) 1.38
CD1c as a target recognition structure for human T lymphocytes: analysis with peripheral blood gamma/delta cells. Eur J Immunol (1990) 1.36
Discrimination of viable and non-viable cells using propidium iodide in two color immunofluorescence. Cytometry (1987) 1.32
T lymphocytes bearing the gamma delta T cell receptor in patients with acute Plasmodium falciparum malaria. J Infect Dis (1990) 1.32
Evidence for involvement of the gamma, delta T cell antigen receptor in cytotoxicity mediated by human alloantigen-specific T cell clones. J Immunol (1989) 1.28
Dual antigenic recognition by cloned human gamma delta T cells. J Clin Invest (1992) 1.04
Antigen-reactive gamma delta T cells in human leishmaniasis. J Immunol (1993) 1.01
The roles of CD4 and CD8 in T cell activation. Semin Immunol (1991) 0.99
Functional expression of CD28 on T cell antigen receptor gamma/delta-bearing T lymphocytes. Eur J Immunol (1989) 0.98
Specificity of human T lymphocytes expressing a gamma/delta T cell antigen receptor. Recognition of a polymorphic determinant of HLA class I molecules by a gamma/delta clone. Eur J Immunol (1989) 0.93
Human cytotoxic lymphocytes. V. Frequency and specificity of gamma delta+ cytotoxic lymphocyte precursors activated by allogeneic or autologous stimulator cells. J Immunol (1990) 0.88
Cloned CD3+ TcR alpha/beta- Ti gamma A- peripheral blood lymphocytes compared to the Ti gamma A+ counterparts: structural differences of the gamma/delta receptor and functional heterogeneity. Eur J Immunol (1988) 0.84
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell (1987) 9.29
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature (1986) 8.36
Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. J Exp Med (1994) 5.60
AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science (1986) 5.58
Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect (1996) 4.93
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med (1996) 4.15
Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens. J Immunol (1981) 3.69
Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. Proc Natl Acad Sci U S A (1981) 3.63
Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man. J Exp Med (1981) 2.93
Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science (2000) 2.71
Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood (1993) 2.59
Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant (2012) 2.46
Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. J Biol Chem (1990) 2.35
Dissection of immunoregulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man. J Immunol (1982) 2.29
Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8. J Immunol (1985) 2.22
Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechniques (1990) 2.22
Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens. J Immunol (1985) 2.20
The immune system in extreme longevity. Exp Gerontol (2007) 2.15
Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J Immunol (1989) 2.13
Dendritic cells in cancer immunotherapy. Annu Rev Immunol (2000) 2.11
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci U S A (2001) 1.85
Monoclonal antibody (B27M2) subdividing HLA-B27. Hum Immunol (1982) 1.81
Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer. J Immunol (1997) 1.80
Functional and quantitative alterations in T lymphocyte subpopulations in acute toxoplasmosis. J Infect Dis (1984) 1.73
Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors. J Immunol (1983) 1.73
Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J Clin Invest (1990) 1.72
Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N Engl J Med (1981) 1.69
Identification of protein intermediates in the processing of the p55 HIV-1 gag precursor in cells infected with recombinant vaccinia virus. J Biol Chem (1989) 1.66
Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance. Am J Transplant (2014) 1.63
CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J Immunol (1998) 1.52
A suppressor T cell of the mixed lymphocyte reaction in man specific for the stimulating alloantigen. Evidence that identity at HLA-D between suppressor and responder is required for suppression. J Exp Med (1978) 1.49
Heterogeneous distribution and transmembrane signaling properties of lymphocyte function-associated antigen (LFA-1) in human lymphocyte subsets. J Immunol (1989) 1.46
Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy. J Immunol (2001) 1.46
Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration. Clin Immunol (1999) 1.45
Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune disease. Arthritis Rheum (1981) 1.41
Production of functional human T-T hybridomas in selection medium lacking aminopterin and thymidine. Proc Natl Acad Sci U S A (1982) 1.41
Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study. Blood (1999) 1.40
[The SAPHO syndrome: a study of 16 cases]. Med Clin (Barc) (1999) 1.39
The estrogenicity of bisphenol A-related diphenylalkanes with various substituents at the central carbon and the hydroxy groups. Environ Health Perspect (1998) 1.33
Discrimination of viable and non-viable cells using propidium iodide in two color immunofluorescence. Cytometry (1987) 1.32
Immunoregulatory T cell circuits in man. Alloantigen-primed inducer T cells activate alloantigen-specific suppressor T cells in the absence of the initial antigenic stimulus. J Exp Med (1983) 1.30
Evidence for an association between CD8 molecules and the T cell receptor complex on cytotoxic T cells. J Immunol (1987) 1.28
Evidence for involvement of the gamma, delta T cell antigen receptor in cytotoxicity mediated by human alloantigen-specific T cell clones. J Immunol (1989) 1.28
Correlation of functional properties of human lymphoid cell subsets and surface marker phenotypes using multiparameter analysis and flow cytometry. Immunol Rev (1983) 1.27
Determination of bisphenol A and related aromatic compounds released from bis-GMA-based composites and sealants by high performance liquid chromatography. Environ Health Perspect (2000) 1.27
CD4 molecules are associated with the antigen receptor complex on activated but not resting T cells. J Immunol (1988) 1.26
Human recombinant interleukin-2 partly reconstitutes deficient in-vitro immune responses of lymphocytes from patients with AIDS. Lancet (1984) 1.22
Human T lymphocyte proliferation induced by a pan-T monoclonal antibody (anti-Leu 4): heterogeneity of response is a function of monocytes. J Immunol (1983) 1.21
Generation of antigen-specific CD8+ CTLs from naive precursors. J Immunol (1994) 1.20
Differentiation of myeloid dendritic cells into CD8alpha-positive dendritic cells in vivo. Blood (2000) 1.20
Dendritic cells injected via different routes induce immunity in cancer patients. J Immunol (2001) 1.19
Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect. J Clin Invest (1980) 1.19
Induction of immunoglobulin secreting cells in the human autologous mixed leukocyte reaction: regulation by helper and suppressor lymphocyte subsets defined with monoclonal antibodies. J Immunol (1981) 1.17
Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus. J Clin Invest (1990) 1.17
Attitudes toward women physicians. A study of 500 clinic patients. West J Med (1974) 1.17
Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol (1991) 1.17
Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation. Am J Transplant (2015) 1.15
Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro. Evidence for preferential binding of natural killer cells. J Clin Invest (1987) 1.14
Blocking of human T lymphocyte functions by anti-Leu-2 and anti-Leu-3 antibodies: differential inhibition of proliferation and suppression. J Immunol (1983) 1.11
Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones. J Immunol (1990) 1.11
Complex alteration of thyroid function in healthy centenarians. J Clin Endocrinol Metab (1993) 1.11
Cascade control of E. coli glutamine synthetase. II. Metabolite regulation of the enzymes in the cascade. Arch Biochem Biophys (1978) 1.11
Utility of formaldehyde fixation for flow cytometry and inactivation of the AIDS associated retrovirus. J Immunol Methods (1986) 1.10
Metastatic follicular thyroid carcinoma to the kidney: a case report. Clin Nucl Med (1999) 1.10
Natural killer lines and clones with apparent antigen specificity. J Exp Med (1990) 1.10
Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity. Transplantation (2000) 1.09
Immune regulation: a critical link between NK cells and CTLs. Immunol Today (1996) 1.08
Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide. J Immunol (1997) 1.08
An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum (1994) 1.08
Degradation of CD4 following phorbol-induced internalization in human T lymphocytes. Evidence for distinct endocytic routing of CD4 and CD3. J Biol Chem (1992) 1.05
Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes. Biochem Pharmacol (1986) 1.04
Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae. Infect Immun (1990) 1.04
Early activation events render T cells susceptible to HIV-1-induced syncytia formation. Role of protein kinase C. J Biol Chem (1991) 1.04
Cultured human epidermal cells do not synthesize HLA-DR. J Invest Dermatol (1982) 1.02
Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity. J Immunol (1989) 1.02
Expression and processing of human immunodeficiency virus type 1 gag and pol genes by cells infected with a recombinant vaccinia virus. J Virol (1989) 1.02
Induction of immunoglobulin-secreting cells in the allogeneic mixed leukocyte reaction: regulation by helper and suppressor lymphocyte subsets in man. J Immunol (1981) 1.02
A human alloreactive inducer T cell clone that selectively activates antigen-specific suppressor T cells. J Immunol (1984) 1.02
Mixed lymphocyte reaction in healthy women with rheumatoid factor. Lack of association with HLA-Dw4. Arthritis Rheum (1979) 1.02
Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method. Hum Immunol (1983) 1.02
Activation of HLA-restricted EBV-specific cytotoxic T cells does not require CD4+ (helper) T cells or exogenous cytokines. J Immunol (1988) 1.02
Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation. J Biol Chem (1991) 1.02
Immunoregulatory T cell circuits in man. Identification of a distinct T cell subpopulation of the helper/inducer lineage that amplifies the development of alloantigen-specific suppressor T cells. J Immunol (1985) 1.01
Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell Immunol (1996) 1.01
Morphological types of Taenia solium cysticerci. Parasitol Today (1989) 1.01
A suppressor T cell of the mixed lymphocyte reaction specific for the HLA-D region in man. J Clin Invest (1978) 1.00
Activation of antigen-specific suppressor T cells in the presence of cyclosporin requires interactions between T cells of inducer and suppressor lineage. J Clin Invest (1983) 1.00
Maturational and functional diversity of human B lymphocytes delineated with anti-Leu-8. J Immunol (1985) 1.00
Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cells. Immunology (1995) 1.00
Ia antigen on peripheral blood mononuclear leukocytes in man. I. Expression, biosynthesis, and function of HLA-DR antigen non-T cells. J Exp Med (1980) 0.98
Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma. J Immunol Methods (1984) 0.98
Immunoglobulin secretion in the human autologous mixed leukocyte reaction. Definition of a suppressor-amplifier circuit using monoclonal antibodies. J Exp Med (1982) 0.98
Identification of an immunostimulating protein from Mycobacterium leprae. Infect Immun (1990) 0.98